{
    "root": "3fa12a10-2619-4a74-b2c5-6ad0cf17b0ff",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Methylene blue",
    "value": "20250306",
    "ingredients": [
        {
            "name": "METHYLENE BLUE",
            "code": "T42P99266K"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "methylene blue injection indicated treatment pediatric adult patients acquired methemoglobinemia .",
    "contraindications": "administer 1 mg/kg intravenously 5-30 minutes . ( 2.1 ) methemoglobin level remains 30 % symptoms persist , give repeat dose 1 mg/kg one hour first dose . ( 2.1 ) administer single dose 1 mg/kg patients moderate severe renal impairment . ( 2.2 )",
    "warningsAndPrecautions": "methylene blue injection , usp supplied 10 ml 2 ml single-dose vials . 10 ml vial contains 50 mg methylene blue , usp clear dark blue solution . 2 ml vial contains 10 mg methylene blue , usp clear dark blue solution . box contains five vials . box 5 vials 50 mg/10 ml ( 0.5 % ) : ndc 70710-1838-5 box 5 vials 10 mg/2 ml ( 0.5 % ) : ndc 70710-1837-5 storage : store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . [ usp controlled room temperature ] unused product waste material disposed accordance local practice . refrigerate freeze . keep vial original package protect light .",
    "adverseReactions": "methylene blue contraindicated following conditions : severe hypersensitivity methylene blue thiazine dye [ ( 5.2 ) ] . patients glucose-6-phosphate dehydrogenase deficiency ( g6pd ) due risk hemolytic anemia [ ( 5.3 , 5.4 ) ] .",
    "indications_original": "Methylene blue injection is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.",
    "contraindications_original": "Administer 1 mg/kg intravenously over 5-30 minutes. ( 2.1 ) If methemoglobin level remains above 30% or if clinical symptoms persist, give a repeat dose of up to 1 mg/kg one hour after the first dose. ( 2.1 ) Administer a single dose of 1 mg/kg in patients with moderate or severe renal impairment. ( 2.2 )",
    "warningsAndPrecautions_original": "Methylene blue injection, USP is supplied in 10 mL and 2 mL single-dose vials. Each 10 mL vial contains 50 mg of methylene blue, USP as a clear dark blue solution. Each 2 mL vial contains 10 mg of methylene blue, USP as a clear dark blue solution. A box contains five vials.\n                  Box of 5 vials of 50 mg/10 mL (0.5%): NDC 70710-1838-5\n                  Box of 5 vials of 10 mg/2 mL (0.5%): NDC 70710-1837-5\n                  \n                     Storage:\n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F). [See USP Controlled Room Temperature]\n                  \n                  Any unused product or waste material should be disposed of in accordance with local practice. \n                  \n                     Do not refrigerate or freeze.\n                  \n                  \n                     Keep the vial in the original package to protect from light.",
    "adverseReactions_original": "Methylene blue is contraindicated in the following conditions:\n                  \n                     Severe hypersensitivity reactions to methylene blue or any other thiazine dye [see Warnings and Precautions (5.2)].\n                     Patients with glucose-6-phosphate dehydrogenase deficiency (G6PD) due to the risk of hemolytic anemia [see Warnings and Precautions (5.3, 5.4)]."
}